This study was terminated in the United States. It is testing darigabat for Panic Disorder.
AnxietyDrugFrom 18 Years to 65 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether Darigabat may be useful for adults experiencing anxiety.
What would participation involve?
Participants may receive Darigabat, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.
Who is it mainly for?
This study appears to be mainly for adults with anxiety.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateStarted: July 31, 2023
Recruitment status
Terminated
Enrollment listed in the registry
80
Sponsor
AbbVie
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT05941442
Official title
A Phase 2, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic Disorder
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT05941442. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
United States · 31 sites
Phoenix, Arizona
Phoenix, Arizona
Site status: Not listed — confirm with the team
Lafayette, California
Lafayette, California
Site status: Not listed — confirm with the team
Los Angeles, California
Los Angeles, California
Site status: Not listed — confirm with the team
Oceanside, California
Oceanside, California
Site status: Not listed — confirm with the team
Orange, California
Orange, California
Site status: Not listed — confirm with the team
Riverside, California
Riverside, California
Site status: Not listed — confirm with the team
San Jose, California
San Jose, California
Site status: Not listed — confirm with the team
Torrance, California
Torrance, California
Site status: Not listed — confirm with the team
Miami, Florida
Miami, Florida
Site status: Not listed — confirm with the team
North Miami Beach, Florida
North Miami Beach, Florida
Site status: Not listed — confirm with the team
Orlando, Florida
Orlando, Florida
Site status: Not listed — confirm with the team
Atlanta, Georgia
Atlanta, Georgia
Site status: Not listed — confirm with the team
Decatur, Georgia
Decatur, Georgia
Site status: Not listed — confirm with the team
Savannah, Georgia
Savannah, Georgia
Site status: Not listed — confirm with the team
Elgin, Illinois
Elgin, Illinois
Site status: Not listed — confirm with the team
Overland Park, Kansas
Overland Park, Kansas
Site status: Not listed — confirm with the team
Boston, Massachusetts
Boston, Massachusetts
Site status: Not listed — confirm with the team
Las Vegas, Nevada
Las Vegas, Nevada
Site status: Not listed — confirm with the team
Berlin, New Jersey
Berlin, New Jersey
Site status: Not listed — confirm with the team
Brooklyn, New York
Brooklyn, New York
Site status: Not listed — confirm with the team
Brooklyn, New York
Brooklyn, New York
Site status: Not listed — confirm with the team
New York, New York
New York, New York
Site status: Not listed — confirm with the team
Rochester, New York
Rochester, New York
Site status: Not listed — confirm with the team
Staten Island, New York
Staten Island, New York
Site status: Not listed — confirm with the team
Monroe, North Carolina
Monroe, North Carolina
Site status: Not listed — confirm with the team
Oklahoma City, Oklahoma
Oklahoma City, Oklahoma
Site status: Not listed — confirm with the team
West Chester, Pennsylvania
West Chester, Pennsylvania
Site status: Not listed — confirm with the team
Austin, Texas
Austin, Texas
Site status: Not listed — confirm with the team
Desoto, Texas
DeSoto, Texas
Site status: Not listed — confirm with the team
Draper, Utah
Draper, Utah
Site status: Not listed — confirm with the team
Everett, Washington
Everett, Washington
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with anxiety. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Darigabat, Placebo. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.
Who might this study be for?
This study may concern people with anxiety; age range: From 18 Years to 65 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by AbbVie, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
